Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: A cross-sectional study

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Thacker, Evan L ^a,b   Muntner, Paul ^a   Zhao, Hong ^a   Safford, Monika M ^c   Curtis, Jeffrey R ^c   Delzell, Elizabeth ^a   Bittner, Vera ^c   Brown, Todd M ^c   Levitan, Emily B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Coronary heart disease; High risk; Medicare claims; Risk stratification

Indexed keywords

AGED; ALGORITHM; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSURANCE; MALE; MEDICARE; PROCEDURES; RISK ASSESSMENT; UNITED STATES;

AGED; ALGORITHMS; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; RISK ASSESSMENT; UNITED STATES;

EID: 84900516836     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-195     Document Type: Article

References (22)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. National Cholesterol Education Program, http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3-rpt.htm
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, Coordinating Committee of the National Cholesterol Education Program, Circulation 2004 110 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516 (Pubitemid 38924592)
3. - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Stone NJ, Robinson J, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PWF, Circulation in press
4. Predictors of nonadherence to statins: a systematic review and meta-analysis. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I, Ann Pharmacother 2010 44 1410 1421 10.1345/aph.1P150 20702755
5. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Lemstra M, Blackburn D, Crawley A, Fung R, Can J Cardiol 2012 28 574 580 10.1016/j.cjca.2012.05.007 22884278
6. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled dose-ranging, phase 2 study. Giugliano RP, Desai NR, Kohli P, Rogers WJ, Somaratne R, Huang F, Liu T, Mohanavelu S, Hoffman EB, McDonald ST, Abrahamsen TE, Wasserman SM, Scott R, Sabatine MS, LAPLACE-TIMI 57 Investigators, Lancet 2013 380 2007 2017
7. Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA, J Am Coll Cardiol 2012 59 2344 2353 10.1016/j.jacc.2012.03.007 22463922
8. A beneficial side effect of the Medicare drug benefit. Platt R, Ommaya A, N Engl J Med 2005 353 2742 3743 10.1056/NEJMp058297 16382059 (Pubitemid 43016812)
9. Predicting hip and major osteoporotic fractures using administrative data. Yun H, Delzell E, Ensrud KE, Kilgore ML, Becker D, Morrisey MA, Curtis JA, Arch Intern Med 2010 170 1940 1941 21098356
10. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim S, Rothman KJ, Liu J, Avorn J, BMC Med Res Methodol 2012 12 180 10.1186/1471-2288-12-180 23181419
11. Design for validation of acute myocardial infarction cases in Mini-Sentinel. Cutrona SL, Toh S, Iyer A, Foy S, Cavagnaro E, Forrow S, Racoosin JA, Goldberg R, Gurwitz JH, Pharmacoepidemiol Drug Saf 2012 21 274 281 22262617
12. Trends and regional variations in abdominal aortic aneurysm repair. http://www.dartmouthatlas.org/downloads/reports/AAA-report-2006.pdf
13. Utilization of lower extremity arterial disease diagnostic and revascularization procedures in Medicare beneficiaries 2000-2007. Harris TJ, Zafar AM, Murphy TP, AJR Am J Roentgenol 2011 197 314 W317 10.2214/AJR.10.6132 21785058
14. National healthcare costs of peripheral arterial disease in the Medicare population. Hirsch AT, Hartman L, Town RJ, Virnig BA, Vasc Med 2008 13 209 215 10.1177/1358863X08089277 18687757
15. Carotid artery stenting procedures: reimbursement information. http://www.bostonscientific.com/templatedata/imports/collateral/Reimbursement/ Vascular-Surgery/rmbgde-Carotid-ReimbursementQuickReference-01-us.pdf
16. CPT codes and reimbursement: cardiac stress testing. http://www.midmark. com/Marketing%20Collateral/CPT-Stress.pdf
17. Billing and coding guidelines for transthoracic echocardiography TTE (CV-026). 2009 http://downloads.cms.gov/medicare-coverage-database/lcd- attachments/28565-28/l28565-cv026-cbg-10012010.pdf
18. Payment Policies for Healthcare Services Provided to Injured Workers and Crime Victims. http://www.lni.wa.gov/ClaimsIns/Providers/Billing/FeeSched/2012/ MARFS/2012PDFs/Chapter6.pdf
19. Billing and Coding Guidelines for CV-016; Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring). http://downloads.cms.gov/ medicare-coverage-database/lcd-attachments/29584-13/L29584-CV016-CBG-040111.pdf
20. The Reasons for Geographic and Racial Differences in Stroke study: objectives and design. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G, Neuroepidemiology 2005 25 135 143 10.1159/000086678 15990444 (Pubitemid 41207066)
21. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA, Epidemiology 2009 20 512 522 10.1097/EDE. 0b013e3181a663cc 19487948
22. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD, J Clin Epidemiol 2001 54 774 781 10.1016/S0895-4356(01)00341-9 11470385 (Pubitemid 32722180)